Gut Bacteria Linked to Suicidal Thoughts in Depression, Study Finds

A new study of patients with major depressive disorder has uncovered intriguing differences in the gut microbiomes of those who experience suicidal thoughts, and it points to an unexpected molecular player: a common intestinal bacterium called Blautia, whose abundance appears to rise in step with the intensity of suicidal ideation. Published in BMC Psychiatry, the research also documented reduced levels of beneficial short-chain fatty acids and elevated markers of systemic inflammation in depressed patients, adding weight to the growing idea that depression is not solely a disorder of the brain but a condition that involves the gut, the immune system, and the trillions of microbes that live in between.

Suicidal ideation refers to thoughts or plans about ending one’s life, and its clinical significance is hard to overstate. According to the World Health Organization, more than 720,000 people die by suicide every year worldwide, with a mortality rate of 9.2 per 100,000. Among patients with major depressive disorder, suicidal thoughts are strikingly common—previous research suggests they affect roughly 53 percent of patients—and they are considered a critical precursor to suicide attempts and suicide completion. Patients who carry these thoughts also tend to have more severe depressive symptoms and respond more poorly to treatment. Because many of them never actively seek help, identifying new biological markers that could flag elevated risk has become an urgent priority for psychiatric research.

The research team, led by Fei Li, Ziwei Jiang, and colleagues at Shanxi Medical University in Taiyuan, China, enrolled 57 patients with major depressive disorder diagnosed under DSM-5 criteria and 57 healthy controls. Depression severity was measured with the 24-item Hamilton Depression Rating Scale, while suicidal ideation was assessed with the Chinese version of the Beck Scale for Suicide Ideation. Using the Beck scale’s items on active and passive suicidal intent, the patients were divided into a group without current suicidal ideation and a group with suicidal ideation, which ultimately comprised 33 patients. All participants provided fecal and fasting blood samples, and everyone with other mental illnesses, serious physical disease, recent antidepressant treatment, inflammatory bowel conditions, or recent use of antibiotics or probiotics was excluded to keep the microbiome data as clean as possible.

The technical workhorse of the study was 16S ribosomal RNA sequencing, a method that reads the genetic barcode of bacterial communities and allows researchers to catalog which microbes are present and in what proportions. The team amplified the V3–V4 hypervariable region of the 16S gene, sequenced the libraries on an Illumina NovaSeq platform, and processed the reads in QIIME2, clustering them into amplicon sequence variants with a median sequencing depth of 53,650 reads per sample. Blood plasma was analyzed separately: C-reactive protein, a stable and widely used marker of systemic inflammation, was quantified by enzyme-linked immunosorbent assay, while the short-chain fatty acids acetic, propionic, and butyric acid were measured with targeted gas chromatography–mass spectrometry using 4-methylvaleric acid as an internal standard.

The metabolic findings were clear-cut. Depressed patients had significantly lower plasma levels of acetic, propionic, and butyric acids than healthy controls, and significantly higher CRP levels. Short-chain fatty acids are produced when gut bacteria ferment complex polysaccharides from the diet, and they are widely recognized as key regulators of the microbiota-gut-brain axis. They fuel the cells lining the colon, maintain the intestinal barrier, modulate immune function through inhibition of histone deacetylase and activation of G protein-coupled receptors, and can even cross the blood-brain barrier to influence neural activity directly. In animal models, oral administration of short-chain fatty acids has been shown to alleviate depression-like behaviors, so their depletion in patients fits a plausible mechanistic picture.

The sequencing data told a complementary story. Alpha diversity analysis showed that healthy controls had significantly higher Good’s coverage than patients without suicidal ideation, and higher Pielou’s evenness and Simpson indices than patients with suicidal ideation; notably, the Simpson index was also significantly higher in the non-suicidal patient group than in the suicidal group. Beta diversity analysis, based on Bray-Curtis distances and tested with PERMANOVA, revealed significant differences in overall community structure among the three groups (pseudo-F = 2.29, FDR-corrected p < 0.01), with both patient groups differing from controls but not from each other. Linear discriminant analysis effect size identified 24 differentially abundant taxa: healthy controls were enriched in Bacteroides, Roseburia, Dialister, Parabacteroides, and Sutterella—genera associated with short-chain fatty acid production—while patients with suicidal ideation were enriched in Bifidobacterium, Blautia, and Dorea.

The correlation analysis sharpened the picture further. Blautia abundance rose in parallel with Beck suicide ideation scores, Hamilton depression scores, and CRP levels, whereas Bacteroides, Roseburia, and Sutterella were negatively correlated with both psychiatric scores. Acetic, propionic, and butyric acids were each inversely correlated with symptom severity, while CRP was positively correlated. To probe whether inflammation could be the conduit between microbe and mind, the researchers built a mediation model in which Blautia predicted suicidal ideation intensity through CRP. After adjusting for age, sex, BMI, and years of education, Blautia significantly predicted CRP (a = 0.2740), CRP significantly predicted Beck scores (b = 0.3710), and the indirect effect of Blautia through CRP was statistically significant, with a 95 percent bootstrap confidence interval that excluded zero.

Then came the caveat that tempers the headline. When depression severity, measured by the Hamilton scale, was added as a covariate, the mediating effect essentially vanished (indirect effect = 0.0012, p = 0.159). The team also ran an exploratory analysis matching 15 pairs of patients with closely comparable depression scores; while Blautia and Veillonellaceae trended higher and Haemophilus lower in the suicidal group, none of those differences survived false discovery rate correction. In other words, the apparent link between Blautia and suicidal thoughts may be largely carried by depression itself, which is a proximal and powerful risk factor for suicidal ideation. With a limited sample and low statistical power, the study does not support an independent pathway from Blautia to suicidal ideation operating separately from depression severity.

The Blautia result is scientifically interesting precisely because the genus is so contradictory. Long regarded as a beneficial, acetic-acid-producing bacterium with probiotic potential, Blautia has also been linked to pro-inflammatory pathways and upregulated endotoxin synthesis in recent work, and fecal microbiota transplantation studies in germ-free mice have associated its persistence with inflammatory responses. Elevated Blautia has been reported in depressed patients, and a post-mortem study of individuals who died by suicide found increased colonic abundance of Blautia and Dorea correlated with inflammation-related metabolic pathways. The authors suggest the genus’s effects may be species-specific and dependent on the host’s microenvironmental state—a reminder that microbial names do not map neatly onto microbial function.

The researchers are candid about the study’s limits: the cross-sectional design cannot establish causation, the sample size is modest, potential subclinical suicidal ideation may linger in the non-suicidal group, and data on diet, smoking, and physical activity were not collected, while 16S sequencing offers only genus-level resolution. Even so, the findings sketch a compelling model in which gut dysbiosis reduces short-chain fatty acid production, compromises the intestinal barrier, fuels systemic inflammation, and—in ways still to be disentangled from depression itself—may contribute to the emergence of suicidal thoughts. The team calls for longitudinal, interventional studies with larger cohorts and metagenomic sequencing to determine whether the microbiome could one day help clinicians identify patients at risk before tragedy strikes.

Subject of Research: Gut microbiota and inflammatory markers associated with suicidal ideation in major depressive disorder

Article Title: Characterization and correlation of gut microbiota in major depressive disorder patients with suicidal ideation

Article References: Li, F., Jiang, Z., Xing, J., Guo, F., Qu, C., Zhang, A., Yang, C., Liu, P., & Sun, N. (2026). Characterization and correlation of gut microbiota in major depressive disorder patients with suicidal ideation. BMC Psychiatry, 26(1), Article 738. https://doi.org/10.1186/s12888-026-08290-9

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08290-9

Keywords: major depressive disorder, suicidal ideation, gut microbiota, Blautia, C-reactive protein, short-chain fatty acids, 16S rRNA sequencing, microbiota-gut-brain axis, inflammation, dysbiosis, Characterization, correlation